Evelo Biosciences, Inc.

NASDAQ:EVLO

0.0225 (USD) • At close September 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2022202120202019201820172016
Operating Activities:
Net Income -114.527-122.176-93.666-85.472-56.946-28.047-13.332
Depreciation & Amortization 2.062.2162.0261.7641.9350.8340.495
Deferred Income Tax 03.219-0.006-0.1660.4060.3010.02
Stock Based Compensation 15.15815.8468.4688.1656.0591.5420.419
Change In Working Capital -9.6662.0687.7653.4741.1642.070.056
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 0.170.1590.837-0.585-0.2210.774-0.043
Other Working Capital -9.8361.9096.9284.0591.3851.2960.099
Other Non Cash Items 5.742.1022.350.2550.1030.0350.028
Operating Cash Flow -101.235-96.725-73.063-71.98-47.279-23.265-12.314
Investing Activities:
Investments In Property Plant And Equipment -0.622-1.519-1.321-3.032-5.462-1.742-1.25
Acquisitions Net 00000010.486
Purchases Of Investments 0000-136.08700
Sales Maturities Of Investments 0005581.2500
Other Investing Activites 00.0380.0060.0020.17100.027
Investing Cash Flow -0.622-1.481-1.31551.97-60.128-1.7429.263
Financing Activities:
Debt Repayment -47.61-14.778-10-1500-4
Common Stock Issued 84.54481.75154.994075.82900
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 44.72115.78910.47119.99286.18348.96719.742
Financing Cash Flow 81.65597.5465.4654.992162.01248.96715.742
Other Information:
Effect Of Forex Changes On Cash -0.454000000
Net Change In Cash -20.656-0.666-8.913-15.01854.60523.9612.691
Cash At End Of Period 49.09869.75470.4279.33394.35139.74615.786